These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19846796)

  • 21. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.
    O'Grady MJ; Retterath AJ; Keenan DB; Kurtz N; Cantwell M; Spital G; Kremliovsky MN; Roy A; Davis EA; Jones TW; Ly TT
    Diabetes Care; 2012 Nov; 35(11):2182-7. PubMed ID: 22875230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.
    van Bon AC; Hermanides J; Koops R; Hoekstra JB; DeVries JH
    J Diabetes Sci Technol; 2010 Jul; 4(4):923-8. PubMed ID: 20663458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
    Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
    Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus).
    Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS
    Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.
    Ly TT; Roy A; Grosman B; Shin J; Campbell A; Monirabbasi S; Liang B; von Eyben R; Shanmugham S; Clinton P; Buckingham BA
    Diabetes Care; 2015 Jul; 38(7):1205-11. PubMed ID: 26049550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
    Leelarathna L; Dellweg S; Mader JK; Allen JM; Benesch C; Doll W; Ellmerer M; Hartnell S; Heinemann L; Kojzar H; Michalewski L; Nodale M; Thabit H; Wilinska ME; Pieber TR; Arnolds S; Evans ML; Hovorka R;
    Diabetes Care; 2014 Jul; 37(7):1931-7. PubMed ID: 24963110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine.
    El-Khatib FH; Jiang J; Damiano ER
    J Diabetes Sci Technol; 2009 Jul; 3(4):789-803. PubMed ID: 20144330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.
    van Bon AC; Luijf YM; Koebrugge R; Koops R; Hoekstra JB; DeVries JH
    Diabetes Technol Ther; 2014 Mar; 16(3):131-6. PubMed ID: 24224750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
    Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
    J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
    Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
    J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.